Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Center for International Blood and Marrow Transplant Research National Marrow Donor Program |
---|---|
Information provided by: | Center for International Blood and Marrow Transplant Research |
ClinicalTrials.gov Identifier: | NCT00795054 |
The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.
Condition | Intervention |
---|---|
Allogeneic Stem Cell Transplant |
Other: Household financial data collection |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family: A Pilot Study |
Estimated Enrollment: | 30 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | December 2011 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
allogeneic stem cell recipients
Pediatric and adult allogeneic stem cell transplant recipients and their care givers.
|
Other: Household financial data collection
Baseline financial survey pre-transplant, financial diary post-transplant every two weeks for 3 months, and financial questionnaire via phone survey at 6, 12, 18 and 24 months post-transplant.
|
Allogeneic hematopoietic stem cell transplantation (HSCT) is the indicated treatment for many life-threatening illnesses affecting both adults and children. Transplant recovery and late effects require long-term medical care. At the same time that the family faces a medical crisis, a resulting financial crisis may also be pending, but is often pushed to the background due to the necessity of first preserving life. A large proportion of patients undergoing HSCT incur significant financial burden from out-of-pocket costs and a decrease in household income. Predetermined variables, both medical and demographic, gathered at the pre-transplant clinical consultation have the potential to predict the patients at greatest financial risk. This study will describe both the out-of-pocket costs and the income changes that may result from HSCT to help patients and their caregivers have a clearer picture of these costs and develop a financial plan. Health care providers can utilize this information to better inform patients and connect them to resources.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Pediatric and adult allogeneic stem cell transplant recipients and their care givers from three U.S. transplant medical centers.
Inclusion Criteria:
Exclusion Criteria:
Contact: Sue Flesch | 612 617-8303 | sflesch@nmdp.org |
Contact: Amy Foley, MA, CCRP | 612 884-8605 | afoley@nmdp.org |
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States, 55455 | |
United States, New York | |
Roswell Park Cancer Institute | |
Buffalo, New York, United States, 14263 | |
United States, Wisconsin | |
Medical College of Wisconsin | |
Milwaukee, Wisconsin, United States, 53226 |
Study Chair: | Navneet Majhail, MD, MS | University of Minnesota / CIBMTR |
Study Chair: | Douglas Rizzo, MD, MS | Medical College of Wisconsin / CIBMTR |
Responsible Party: | National Marrow Donor Program ( Kate Pederson, MSW / Principal Investigator ) |
Study ID Numbers: | CIBMTR HS 07-02 |
Study First Received: | November 19, 2008 |
Last Updated: | November 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00795054 |
Health Authority: | United States: Institutional Review Board |
Allogeneic stem cell transplant Financial impact |